Evidence map›Paper›PMID 19470834›Full record

Trial reportAmerican journal of physiology. Endocrinology and metabolism2009

Relative effects of estrogen, age, and visceral fat on pulsatile growth hormone secretion in healthy women.

Johannes D Veldhuis, Susan B Hudson, Dana Erickson, Joy N Bailey, George Ann Reynolds, Cyril Y Bowers

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in American journal of physiology. Endocrinology and metabolism, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Biological effects of growth hormone on carbohydrate and lipid metabolism.Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society · 2010
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Johannes D VeldhuisDepartments of Internal Medicine, Endocrine Research Unit, Clinical Translational Research Unit, Mayo Medical and Graduate Schools of Medicine, Mayo Clinic, Rochester, Minnesota, USA. veldhuis.johannes@mayo.edu
Susan B Hudson
Dana Erickson
Joy N Bailey
George Ann Reynolds
Cyril Y Bowers
Tulane University · USWinnMed · USInstitute of Nutrition, Metabolism and Diabetes · CAMayo Clinic in Arizona · US

Funding

ZESTRIL VS. VERAPAMIL IN THE TREATMENT OF HYPERTENSIONM01RR000585 · NCRR · MAYO CLINIC ROCHESTER · PI RIZZA, ROBERT A. · 1985 to 2006
$30.4M
PILOT--PILOT/FEASIBILITY PROGRAMP30DK063609 · NIDDK · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI KELLER, SUSANNA R · 2003 to 2007
$5.7M
Age-Dependent Estrogen-Independent Mechanism of Hyposomatotropism in WomenR01AG029362 · NIA · MAYO CLINIC ROCHESTER · PI VELDHUIS, JOHANNES D · 2007 to 2016
$4.0M
Intraislet network control of glucagon secretionR21DK072095 · NIDDK · UNIVERSITY OF VIRGINIA · PI FARHI, LEON S · 2006 to 2007
$403k
NCRR NIH HHS M01 RR000585NCRR NIH HHS MO1 RR-00585NIA NIH HHS AG-29362NIDDK NIH HHS DK-063609NIDDK NIH HHS R21 DK-072095
6 · The paper itself

Abstract

Growth hormone (GH) secretion is subject to complex regulation. How pre- and postmenopausal age (PRE, POST), estradiol (E(2)) availability, and abdominal visceral fat (AVF) jointly affect peptidyl-secretagogue drive of GH secretion is not known. To this end, healthy PRE (n = 20) and POST (n = 22) women underwent a low- vs. high-E(2) clamp before receiving a continuous intravenous infusion of GH-releasing hormone (GHRH) or GH-releasing peptide (GHRP-2). According to analysis of covariance, PRE and POST women achieved age-independent hypo- and euestrogenemia under respective low- and high-E(2) clamps. All four of age (P < 0.001), E(2) status (P = 0.006), secretagogue type (P < 0.001), and an age x peptide interaction (P = 0.014) controlled pulsatile GH secretion. Independently of E(2) status, POST women had lower GH responses to both GHRH (P = 0.028) and GHRP-2 (P < 0.001) than PRE women. Independently of age, GHRP-2 was more stimulatory than GHRH during low E(2) (P = 0.011) and high E(2) (P < 0.001). Stepwise forward-selection multivariate analysis revealed that computerized tomographic estimates of AVF explained 22% of the variability in GHRH action (P = 0.002), whereas age and E(2) together explained 60% of the variability in GHRP-2 drive (P < 0.001). These data establish that age, estrogen status, and AVF are triple covariates of continuous peptide-secretagogue drive of pulsatile GH secretion in women. Each factor must be controlled for to allow valid comparisons of GH-axis activity.

Indexed as

AdolescentAdultAgedAgingEstradiolFemaleGonadotropin-Releasing HormoneHealthHuman Growth HormoneHumansIntra-Abdominal FatLeuprolideMiddle AgedPlacebosPulsatile FlowYoung AdultEstradiolGonadotropin-Releasing HormoneHuman Growth HormoneLeuprolidePlacebos

Identifiers

PMID19470834
PMCPMC2724113
OpenAlexW2166437917

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.